5856.T
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
The company maintains a strong liquidity position, with a current ratio of 2.01 and cash and equivalents amounting to 1,829,499,000 JPY, indicating a solid ability to meet short-term obligations. The price-to-book ratio of 0.22 and price-to-tangible-book ratio of 0.22 suggest that the company is trading at a significant discount to its book value, potentially indicating undervaluation or asset-heavy operations.
Profitability metrics show a return on equity of 6.65% and a return on assets of 3.14%, which are below the typical thresholds for high-performing firms in the retail sector. The operating margin, calculated as operating income of 724,254,000 JPY on revenue of 10,311,719,000 JPY, is 7.03%, which is in line with the industry median for food retailers.
The company's revenue is primarily concentrated in its domestic market, with no significant international operations disclosed. This concentration may expose the company to regional economic fluctuations and regulatory changes. The company's growth trajectory is expected to remain stable, with no significant changes in revenue or earnings projected for the next fiscal year.
Risk factors include a low liquidity risk and a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio of 0.46 indicates a conservative capital structure, reducing financial risk. Recent events, including the latest financial filings and transcripts, have not indicated any material changes in the company's operations or strategic direction.
- The company has a strong liquidity position with a current ratio of 2.01.
- The company is trading at a significant discount to its book value, as indicated by a price-to-book ratio of 0.22.
- Profitability metrics are below typical thresholds for high-performing firms in the retail sector.
- The company's revenue is primarily concentrated in its domestic market, which may expose it to regional economic fluctuations.
- The company maintains a conservative capital structure with a debt-to-equity ratio of 0.46.
- **margin_outlook_rationale**: The company's operating margin is expected to remain stable due to consistent cost management and pricing strategies.
- **rd_outlook_rationale**: Research and development spending is not a significant factor in the company's operations, as it focuses on retail rather than product innovation.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 5856.T Market data — financials · 2026-05-26
- Life Intelligent Enterprise Holdings Co Ltd Market data — analyst estimates · 2026-05-26